finance.yahoo.com ·
kimball ke q3 2026 earnings 152044279
Topic context
This topic has been covered 317571 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedKimball Electronics, an electronics manufacturing services (EMS) provider, reported Q3 earnings with medical segment growth outpacing other verticals. The 17% medical growth signals strong demand for respiratory care, imaging, and drug delivery devices, benefiting medical device OEMs and contract manufacturers. The overall sales decline is due to a prior-year nonrecurring item; adjusted sales up ~1%. No major supply chain disruption or scarcity identified.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Kimball Q3 FY2026 net sales $353M, +3.4% QoQ, -6% YoY due to nonrecurring $24M inventory sale in Q3 2025.
- Medical vertical grew 17% YoY to $106M, 30% of total sales.
- North America accounted for nearly half of sales; growth driven by respiratory care, imaging systems, drug delivery devices.
Kimball's overall sales decline indicates stable industrial demand with no major changes expected.
Sign in to see all sector verdicts, full thesis and counter-argument debate.
Sector impact at a glance
- GLOBAL_INDUSTRIALSshort
